Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open‐label pilot study von Tremaine, W. J., Brzezinski, A., Katz, J. A., Wolf, D. C., Fleming, T. J., Mordenti, J., Strenkoski‐Nix, L. C., Kurth, M. C.

Volltext

Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects von Strenkoski-Nix, LC, Ermer, J, DeCleene, S, Cevallos, W, Mayer, PR

Volltext

Pharmacodynamic Interactions of Antibiotics Alone and in Combination von Schentag, Jerome J., Strenkoski-Nix, Laura C., Nix, David E., Forrest, Alan

Volltext

Pharmacodynamic Interactions of Ciprofloxacin, Piperacillin, and Piperacillin/Tazobactam in Healthy Volunteers von Strenkoski-Nix, Laura C., Forrest, Alan, Schentag, Jerome J., Nix, David E.

Volltext

Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titers von NIX, D. E, WILTON, J. H, HYATT, J, THOMAS, J, STRENKOSKI-NIX, L. C, FORREST, A, SCHENTAG, J. J

Volltext